Method for treating atrophic age related macular degeneration
Compositions and methods for treating dry age related macular degeneration (dry AMO) by administration to an intraocular location of an anti-neovascular agent (such as bevacizumab) in either a liquid or solid polymeric vehicle (or both), such as a biodegradable hyaluronic acid or PLGA (or PLA).
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.07.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compositions and methods for treating dry age related macular degeneration (dry AMO) by administration to an intraocular location of an anti-neovascular agent (such as bevacizumab) in either a liquid or solid polymeric vehicle (or both), such as a biodegradable hyaluronic acid or PLGA (or PLA). |
---|---|
Bibliography: | Application Number: US201414324630 |